Growth Metrics

Dynavax Technologies (DVAX) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Dynavax Technologies (DVAX) over the last 12 years, with Q3 2025 value amounting to $14.4 million.

  • Dynavax Technologies' Other Operating Expenses rose 1008.1% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.6 million, marking a year-over-year increase of 4888.43%. This contributed to the annual value of $49.4 million for FY2024, which is 1957.55% down from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Other Operating Expenses is $14.4 million, which was up 1008.1% from $14.0 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Other Operating Expenses high stood at $82.4 million for Q2 2022, and its period low was $8.7 million during Q4 2023.
  • Its 5-year average for Other Operating Expenses is $31.5 million, with a median of $14.8 million in 2021.
  • As far as peak fluctuations go, Dynavax Technologies' Other Operating Expenses soared by 219539.01% in 2021, and later plummeted by 8878.67% in 2023.
  • Over the past 5 years, Dynavax Technologies' Other Operating Expenses (Quarter) stood at $74.0 million in 2021, then increased by 4.7% to $77.5 million in 2022, then tumbled by 88.79% to $8.7 million in 2023, then skyrocketed by 54.33% to $13.4 million in 2024, then grew by 7.4% to $14.4 million in 2025.
  • Its last three reported values are $14.4 million in Q3 2025, $14.0 million for Q2 2025, and $24.7 million during Q1 2025.